Projects funded by the NCN
Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders
2021/43/B/NZ7/02855
Keywords:
5-HT3/5-HT6 antagonism dual acting compounds neutral antagonism inverse agonism schizophrenia irritable-bowel syndrom
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 15
Call: OPUS 22 - announced on 2021-09-15
Amount awarded: 3 601 928 PLN
Project start date (Y-m-d): 2022-07-18
Project end date (Y-m-d): 2026-07-17
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.